Simon, Christopher
SEC CIK 1674993 · EDGAR
BoughtSold
Most active insiders at SHC, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | WARBURG PINCUS & CO. | Dir, 10% | — | $579.51M |
| 2 | Warburg Pincus Partners II, L.P. | Dir, 10% | — | $510.75M |
| 3 | Warburg Pincus Partners GP LLC | Dir, 10% | — | $387.78M |
| 4 | GTCR FUND XI/A LP | Dir, 10% | — | $293.62M |
| 5 | Warburg Pincus Private Equity XI-C, L.P. | Dir, 10% | — | $281.70M |
| 6 | GTCR INVESTMENT XI LLC | Dir, 10% | — | $193.17M |
| 7 | WARBURG PINCUS LLC | Dir, 10% | — | $158.73M |
| 8 | GTCR CO-INVEST XI LP | Dir, 10% | — | $152.70M |
| 9 | Petras Michael B. Jr. | Executive COB, Dir | — | $33.51M |
| 10 | Rutz Michael P | Pres of Sterigenics | — | $2.83M |
| 16 | Simon, Christopher | Dir | — | — |
Transactions 28
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-27 17:21 | 2026-05-22 | SHC | Sotera Health Co | Simon, Christopher | Dir | A - Grant | $0.00 | +15.0K | 34.1K | +78% | $0 | |
| 2026-05-19 17:28 | 2026-05-15 | HAE | HAEMONETICS CORP | Simon, Christopher | Pres, CEO, Dir | F - Tax | $56.29 | -9,681 | 366.4K | -3% | -$544.9K | |
| 2026-05-19 17:28 | 2026-05-15 | HAE | HAEMONETICS CORP | Simon, Christopher | Pres, CEO, Dir | A - Grant | — | +78.3K | 444.7K | +21% | — | |
| 2025-06-03 | 2025-05-30 | HAE | HAEMONETICS CORP | Simon, Christopher | Pres, CEO, Dir | F - Tax | $69.38 | -26.2K | 375.5K | -7% | -$1.82M | |
| 2025-06-03 | 2025-05-30 | HAE | HAEMONETICS CORP | Simon, Christopher | Pres, CEO, Dir | A - Grant | $0.00 | +66.7K | 401.8K | +20% | $0 | |
| 2025-05-27 | 2025-05-22 | SHC | Sotera Health Co | Simon, Christopher | Dir | A - Grant | $0.00 | +19.1K | 19.1K | New | $0 | |
| D | 2025-05-20 | 2025-05-16 | HAE | HAEMONETICS CORP | Simon, Christopher | Pres, CEO, Dir | A - Grant | — | +21.4K | 335.1K | +7% | — |
| M | 2025-05-19 | 2025-05-15+ | HAE | HAEMONETICS CORP | Simon, Christopher | Pres, CEO, Dir | F - Tax | $70.08 | -9,480 | 320.8K | -3% | -$664.3K |
| 2024-09-03 | 2024-08-29 | HAE | HAEMONETICS CORP | Simon, Christopher | Pres, CEO, Dir | J - Other | $75.56 | -39.7K | 322.8K | -11% | -$3.00M | |
| D | 2024-06-07 | 2024-06-06 | HAE | HAEMONETICS CORP | Simon, Christopher | Pres, CEO, Dir | F - Tax | $87.38 | -71.3K | 362.5K | -16% | -$6.23M |
| D | 2024-06-07 | 2024-06-06 | HAE | HAEMONETICS CORP | Simon, Christopher | Pres, CEO, Dir | M - OptEx | $41.64 | +104.5K | 433.9K | +32% | +$4.35M |
| 2024-05-29 | 2024-05-28 | HAE | HAEMONETICS CORP | Simon, Christopher | Pres, CEO, Dir | A - Grant | $0.00 | +106.1K | 371.1K | +40% | $0 | |
| 2024-05-29 | 2024-05-28 | HAE | HAEMONETICS CORP | Simon, Christopher | Pres, CEO, Dir | F - Tax | $95.73 | -41.7K | 329.4K | -11% | -$4.00M | |
| D | 2024-05-21 | 2024-05-17 | HAE | HAEMONETICS CORP | Simon, Christopher | Pres, CEO, Dir | F - Tax | $95.73 | -4,037 | 250.4K | -2% | -$386.5K |
| D | 2024-05-21 | 2024-05-17 | HAE | HAEMONETICS CORP | Simon, Christopher | Pres, CEO, Dir | A - Grant | — | +14.6K | 265.0K | +6% | — |
| M | 2024-05-17 | 2024-05-15+ | HAE | HAEMONETICS CORP | Simon, Christopher | Pres, CEO, Dir | F - Tax | $95.54 | -3,387 | 256.4K | -1% | -$323.6K |
| 2024-03-13 | 2024-03-11 | HAE | HAEMONETICS CORP | Simon, Christopher | Pres, CEO, Dir | G - Gift | $0.00 | -38.9K | 257.5K | -13% | $0 | |
| D | 2023-06-30 | 2023-06-29 | HAE | HAEMONETICS CORP | Simon, Christopher | Pres, CEO, Dir | F - Tax | $84.84 | -117.7K | 296.4K | -28% | -$9.98M |
| D | 2023-06-30 | 2023-06-29 | HAE | HAEMONETICS CORP | Simon, Christopher | Pres, CEO, Dir | M - OptEx | $28.62 | +196.7K | 414.1K | +91% | +$5.63M |
| 2023-05-19 | 2023-05-18 | HAE | HAEMONETICS CORP | Simon, Christopher | Pres, CEO, Dir | F - Tax | $83.34 | -3,839 | 217.4K | -2% | -$319.9K | |
| D | 2023-05-17 | 2023-05-15 | HAE | HAEMONETICS CORP | Simon, Christopher | Pres, CEO, Dir | A - Grant | — | +18.2K | 222.8K | +9% | — |
| D | 2023-05-17 | 2023-05-16 | HAE | HAEMONETICS CORP | Simon, Christopher | Pres, CEO, Dir | F - Tax | $89.21 | -1,586 | 221.2K | -0.7% | -$141.5K |
| 2023-05-16 | 2023-05-12 | HAE | HAEMONETICS CORP | Simon, Christopher | Pres, CEO, Dir | F - Tax | $88.16 | -854 | 204.6K | -0.4% | -$75.3K | |
| 2022-11-15 | 2022-11-11 | HAE | HAEMONETICS CORP | Simon, Christopher | Pres, CEO, Dir | G - Gift | $0.00 | -8,600 | 205.1K | -4% | $0 | |
| 2022-06-15 | 2022-06-13 | HAE | HAEMONETICS CORP | Simon, Christopher | Pres, CEO, Dir | S - Sale | $62.60 | -1,148 | 213.7K | -0.5% | -$71.9K | |
| 2022-05-23 | 2022-05-19 | HAE | HAEMONETICS CORP | Simon, Christopher | Pres, CEO, Dir | S - Sale | $59.10 | -2,496 | 214.9K | -1% | -$147.5K | |
| D | 2022-05-18 | 2022-05-16 | HAE | HAEMONETICS CORP | Simon, Christopher | Pres, CEO, Dir | S - Sale | $56.10 | -832 | 191.3K | -0.4% | -$46.7K |
| D | 2022-05-18 | 2022-05-16 | HAE | HAEMONETICS CORP | Simon, Christopher | Pres, CEO, Dir | A - Grant | — | +26.0K | 217.4K | +14% | — |
Purchase Sale Sale after option exercise All abbreviations